Literature DB >> 28250469

Gut microbiota: Diagnosing IBD with the gut microbiome.

Iain Dickson.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28250469     DOI: 10.1038/nrgastro.2017.25

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  2 in total

1.  A microbial signature for Crohn's disease.

Authors:  Victoria Pascal; Marta Pozuelo; Natalia Borruel; Francesc Casellas; David Campos; Alba Santiago; Xavier Martinez; Encarna Varela; Guillaume Sarrabayrouse; Kathleen Machiels; Severine Vermeire; Harry Sokol; Francisco Guarner; Chaysavanh Manichanh
Journal:  Gut       Date:  2017-02-07       Impact factor: 23.059

2.  Dynamics of the human gut microbiome in inflammatory bowel disease.

Authors:  Jonas Halfvarson; Colin J Brislawn; Regina Lamendella; Yoshiki Vázquez-Baeza; William A Walters; Lisa M Bramer; Mauro D'Amato; Ferdinando Bonfiglio; Daniel McDonald; Antonio Gonzalez; Erin E McClure; Mitchell F Dunklebarger; Rob Knight; Janet K Jansson
Journal:  Nat Microbiol       Date:  2017-02-13       Impact factor: 17.745

  2 in total
  8 in total

1.  Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease - What the Clinician Needs to Know.

Authors:  David Chen; Clifton Fulmer; Ilyssa O Gordon; Sana Syed; Ryan W Stidham; Niels Vande Casteele; Yi Qin; Katherine Falloon; Benjamin L Cohen; Robert Wyllie; Florian Rieder
Journal:  J Crohns Colitis       Date:  2022-03-14       Impact factor: 10.020

2.  MATERNAL GUT MICROBIOTA IN PREGNANCIES RESULTING IN DOWN SYNDROME NEWBORNS - A PILOT STUDY.

Authors:  Mehmet Hursitoglu; Alev Kural; Sibel Kuras; Esra Akdeniz; Salim Sezer; Sema Suzen Caypinar; Cemal Kazezoglu; Bulent Yaprak; Faruk Karandere; Hamit Zafer Guven
Journal:  Acta Clin Croat       Date:  2021-12       Impact factor: 0.932

3.  Xuedan Sustained Release Pellets Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Targeting Gut Microbiota and MAPK Signaling Pathways.

Authors:  Yingchun Zhang; Dan Feng; Yue Zeng; Hanyu Zhang; Xiaohong Du; Yang Fu; Xinhui Wang; Dingyue Lian; Ruikang Wang; Hongyu Xiao; Ning Wei; Fuqiang Zhai; Hanru Liu
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

Review 4.  Microbiome and metabolome data integration provides insight into health and disease.

Authors:  Michael Shaffer; Abigail J S Armstrong; Vanessa V Phelan; Nichole Reisdorph; Catherine A Lozupone
Journal:  Transl Res       Date:  2017-07-14       Impact factor: 7.012

5.  A Two-Time Point Analysis of Gut Microbiota in the General Population of Buenos Aires and Its Variation Due to Preventive and Compulsory Social Isolation During the COVID-19 Pandemic.

Authors:  Pablo Aguilera; María Florencia Mascardi; Fiorella Sabrina Belforte; Ayelén Daiana Rosso; Sofía Quesada; Ignacio Llovet; Gregorio Iraola; Julieta Trinks; Alberto Penas-Steinhardt
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640

6.  Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases.

Authors:  Heather Armstrong; Misagh Alipour; Rosica Valcheva; Michael Bording-Jorgensen; Juan Jovel; Deenaz Zaidi; Prachi Shah; Yuefei Lou; Cory Ebeling; Andrew L Mason; Dawson Lafleur; Jeremy Jerasi; Gane K-S Wong; Karen Madsen; Matthew W Carroll; Hien Q Huynh; Levinus A Dieleman; Eytan Wine
Journal:  Microbiome       Date:  2019-01-03       Impact factor: 14.650

Review 7.  Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.

Authors:  Manoj Kumar; Mathieu Garand; Souhaila Al Khodor
Journal:  J Transl Med       Date:  2019-12-13       Impact factor: 8.440

8.  The Cu(II) Reductase RclA Protects Escherichia coli against the Combination of Hypochlorous Acid and Intracellular Copper.

Authors:  Rhea M Derke; Alexander J Barron; Caitlin E Billiot; Ivis F Chaple; Suzanne E Lapi; Nichole A Broderick; Michael J Gray
Journal:  mBio       Date:  2020-09-29       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.